Brain Health and its Relationship to MS
Date for your diary!
Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive Multiple Sclerosis patients
NUI Galway are looking for people to take part in a new programme
Causes, attributions and intervention needs
Queens researchers in £2 million bid to reverse the damage of Multiple Sclerosis
Survey is now closed